Cargando…
COVID-19 vaccination in adults with inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) are not at increased risk of SARS-CoV-2 infection compared to the general population, and most are not at increased risk for severe disease. COVID-19 is nonetheless common, and vaccination is critical. Four safe and efficacious vaccines are now availabl...
Autores principales: | Lutz, Megan, Lazarus, Sarah, Caldera, Freddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203854/ https://www.ncbi.nlm.nih.gov/pubmed/37234702 http://dx.doi.org/10.1177/17562848231173130 |
Ejemplares similares
-
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: van de Pol, Natasja, et al.
Publicado: (2023) -
COVID-19 is not associated with worse long-term inflammatory bowel
disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022) -
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease
por: Stone, Katherine L., et al.
Publicado: (2023) -
COVID-19 and celiac disease: a review
por: Cohen, Brandon S., et al.
Publicado: (2023) -
COVID-19 in patients with liver disease and liver transplant: clinical implications, prevention, and management
por: Perreault, Gabriel, et al.
Publicado: (2023)